NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-139-2006-0-AU-01 Development Of Dengue Virus Vaccine Components AU DIV 2023255035 Pending
NIAID E-089-2022-0-US-03 PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE US National Stage 18/557,396 Pending
NIAID E-174-2023-0-US-02 Self-Assembling Nanoparticles US ORD 18/494,491 Pending
NIAID E-221-2022-2-US-01 LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE US National Stage 18/288,358 Pending
NIAID E-025-2023-0-PC-01 Combination Treatment For Treating Cancer PCT PCT PCT/US2023/077765 Pending
NIAID E-174-2023-0-PC-01 Self-Assembling Nanoparticles PCT PCT PCT/US2023/077767 Pending
NCI E-165-2020-0-HK-01 HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation HK EP 62023081216.1 Pending
NCI E-065-2021-0-AU-01 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF AU National Stage 2022241765 Pending
NIAID E-002-2023-2-PC-01 Vesicular Stomatitis Virus-Based Sudan Virus Vaccine PCT PCT PCT/US2023/077444 Pending
NIAID E-228-2016-1-US-01 STABILIZED GROUP 2 INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US CON 18/491,193 Pending
NICHD E-058-2021-0-JP-01 La Protein As A Novel Regulator Of Osteoclastogenesis JP National Stage 2023-553206 Pending
NIAID E-214-2021-2-KR-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides KR National Stage 10-2023-0147135 Pending
NHLBI E-239-2023-0-US-01 PRAZOLE-BASED ANTIVIRAL THERAPEUTICS US 63/545,080 Expired
NIA E-062-2021-0-US-02 HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE US National Stage 18/287,630 Pending
NIAMS E-244-2020-0-CN-01 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 CN National Stage 202280029673.2 Issued
NIA E-197-2022-0-PC-01 ISLET AMYLOID POLYPEPTIDE ISOFORMS AND PEPTIDES AND METHODS OF USE PCT PCT PCT/US2023/077173 Pending
NCI E-118-2021-0-EP-01 Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors EP National Stage 22738126.6 Pending
NIAID E-018-2018-0-JP-11 CHIMERIC VECTORS JP DIV 2023-179912 Pending
NIAID E-239-2020-0-IN-01 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE IN National Stage 202317071027 Pending
NCI E-344-2013-0-AU-02 TEM8 Antibodies and Their Use AU DIV 2023251389 Pending
NCI E-191-2019-0-US-02 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION US National Stage 18/286,911 Pending
NCI E-065-2021-0-EP-01 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF EP National Stage 22719666.4 Pending
NIAID E-001-2024-1-US-02 Viral Strain Serology Assays US 63/590,109 Expired
NCI E-216-2022-0-PC-01 METHODS OF IDENTIFYING TARGETS OF CANCER DRUGS
AND OF TREATING CANCER 		PCT PCT PCT/US2023/076704 Pending
NIAID E-239-2020-0-US-02 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE US National Stage 18/555,137 Pending
NIAID E-239-2020-0-CA-01 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE CA National Stage 3216466 Pending
NIAID E-064-2016-1-AU-01 SUBSTITUTIONS-MODIFIED PREFUSION RSV F PROTEINS AND THEIR USE AU DIV 2023248085 Pending
NIAID E-037-2021-1-CN-06 Antibodies Targeting The Spike Protein Of Coronaviruses CN National Stage 202280027556.2 Pending
NICHD E-210-2021-0-US-04 KITS AND METHODS FOR PREDICTION AND TREATMENT OF PREECLAMPSIA US CON 18/482,286 Pending
NINDS E-130-2022-3-EP-02 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE EP DIV 23202240.0 Pending
NCI E-237-2017-2-EA-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 EA DIV 202392526 Pending
NIAID E-047-2024-0-US-01 GENERATION OF ANTIGEN-SPECIFIC T AND B CELLS USING ENGINEERED COMMENSALS US 63/588,398 Expired
NIAID E-239-2020-0-EP-01 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE EP National Stage 22724539.6 Pending
NCI E-225-2024-0-US-01 Novel autophagy modulating compounds and compositions and methods of treating neurodegenerative disease US 63/542,321 Expired
NCI E-118-2021-0-CA-01 Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors CA National Stage 3216228 Pending
NHLBI E-090-2020-1-US-01 NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE US CIP 18/480,306 Pending
NCI E-182-2017-0-SG-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION SG DIV 10202302822Q Pending
NCI E-171-2018-7-JP-01 MODIFIED CELLS AND METHODS OF THERAPY JP DIV 2023-171191 Pending
NCI E-166-2023-0-US-01 CANCER VACCINE AND METHOD OF USE THEREOF US 63/541,902 Abandoned
NCI E-253-2023-0-US-01 INTERFERON LAMBDA 4 AND USES THEREOF FOR TREATING HEPATIC INFLAMMATION AND LIVER DISEASE US 63/586,936 Expired
NCI E-231-2023-0-US-01 COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELL-BASED VACCINES WITH ENHANCED EFFICACY US 63/586,629 Expired
NEI E-155-2023-0-US-01 STIRRED BIOREACTOR SYSTEM US 63/541,656 Expired
NIDA E-208-2022-0-PCT-01 Dopamine D3/D2 Receptor Partial Agonists For The Treatment Of Neuropsychiatric Disorders PCT PCT PCT/US2023/033932 Pending
NHLBI E-223-2022-0-PC-01 Physiological Navigation In MRI Using Inherent Slab-selective Free-induction-decay Signal PCT PCT PCT/US2023/033997 Pending
NCI E-237-2017-1-SG-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION SG DIV 10202302739V Pending
NHLBI E-160-2023-0-US-01 N-Lactoyl-Phenylalanine (Lac-Phe) compound derivatives US 63/585,791 Expired
NIDDK E-001-2022-0-US-02 MOTOR FOR A MR ELASTOGRAPHY TRANSDUCER US CON 18/474,332 Pending
NCATS E-039-2021-0-EP-01 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION EP National Stage 22714325.2 Pending
CC E-241-2023-0-US-01 GAIT ASSISTANCE SYSTEMS AND METHODS OF CONTROL THEREOF US 63/539,898 Expired
NCI E-494-2013-0-AU-01 Methods of Preparing Anti-human Papillomavirus Antigen T Cells AU DIV 2023233209 Pending